Bryan J Salvatore

EVP Bryan J Salvatore sells 16,394 shares of THG at $185.76 for $3.0M; retains 29,069 shares post-transaction.

Bryan J Salvatore sold 16,394 shares representing -36.1% of his pre-transaction holdings, reducing his stake from 45,463 shares to 29,069 shares at $185.76 per share. The sale occurred when the stock is trading -6.3% from its 52-week high of $199.59, and his cross-ticker track record shows a 90d well-timed rate of 0.00% across 6 prior sells. At THG specifically, his 5 prior sales each showed positive 90-day returns (ranging from +2.0% to +3.0%), indicating those prior sales were not well-timed as the stock rose after each sell. THG trades at a P/E of 9.07 with recent quarterly revenue of $1,701,400,000.00 and annual revenue growth of +5.7%, providing fundamental context for evaluating the trade against market valuation.

THG EVP Salvatore sold 10,526 shares in 3 transactions for $1,753,605.01 on 2025-05-07; holds 25,863 post-sale.

Salvatore Bryan J, Executive Vice President at Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,753,605.01 on 2025-05-07, reducing his holdings by -28.9% to 25,863 shares. The sales occurred at prices ranging from $166.12 to $167.76 per share (blended average $166.60), close to the current price of $166.24 and within the 52-week range of $120.84–$175.14. His same-ticker prior sales in March 2025 showed modest near-term positive returns (30-day returns of +1.4% to +2.5%), though these outcomes remain incomplete at the 90-day measurement point. The transaction is sized at approximately 28.9% of his pre-transaction holdings, representing a substantial reduction in equity exposure for an executive officer at a company with solid fundamentals (P/E 13.62, $1.6B quarterly revenue, +4.1% annual growth).

EVP Salvatore Bryan J sells 10,526 shares for $1,811,530.90 via scheduled 10b5-1 plan at THG

Salvatore Bryan J, Executive Vice President of Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,811,530.90 on 2025-03-03 at blended average price of $172.10. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2024-11-27, meaning the sale was scheduled rather than discretionary. Post-transaction holdings stand at 25,835 shares, representing a 28.9% reduction from pre-transaction levels of 36,361 shares. As a scheduled disposition under Rule 10b5-1, this transaction carries no timing signal and reflects a planned execution rather than an active market judgment by the insider.